Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$14.95 USD
-0.20 (-1.32%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $15.04 +0.09 (0.60%) 7:46 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Bottom 38% (154 out of 250)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.33 | 1.42 | 9.99 |
Current Quarter Estimate | -2.96 | 1.25 | 57.00 |
Year Ago Quarter Estimate | -3.84 | -4.28 | 52.54 |
Next Quarter Estimate | -3.29 | 1.37 | 61.00 |
Next Year Estimate | -13.45 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 5.46 | 17.20 | 15.67 |
Next Year | -6.32 | 16.30 | 9.31 |
Last 5 Years | NA | 0.10 | 8.10 |
Next 5 Years | NA | 14.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 1.64 |
Price/Book (MRQ) | 2.55 | 1.35 |
Price/Cash Flow (MRFY) | NA | 10.85 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -55.42% |
Return on Equity (TTM) | -120.58% | -57.25% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.